<br>        Inclusion Criteria:<br><br>          -  Adult (according to local legislation) male or female patient<br><br>          -  Chronic hepatitis C (CHC)<br><br>          -  Patients naïve to CHC treatment or patients who received prior interferon-based<br>             therapy for CHC for whom data on treatment received and treatment outcome is<br>             available; information on fibrosis stage prior to previous treatment is also required<br><br>        Exclusion Criteria:<br><br>          -  Co-infection with hepatitis B<br><br>          -  History or evidence of decompensated liver disease<br><br>          -  History of major organ transplantation with an existing functional graft (including<br>             liver transplantation)<br><br>          -  End stage renal disease<br>      ;<br>        Inclusion Criteria:<br><br>          -  Adult (according to local legislation) male or female patient<br><br>          -  Chronic hepatitis C (CHC)<br><br>          -  Patients naïve to CHC treatment or patients who received prior interferon-based<br>             therapy for CHC for whom data on treatment received and treatment outcome is<br>             available; information on fibrosis stage prior to previous treatment is also required<br><br>        Exclusion Criteria:<br><br>          -  Co-infection with hepatitis B<br><br>          -  History or evidence of decompensated liver disease<br><br>          -  History of major organ transplantation with an existing functional graft (including<br>             liver transplantation)<br><br>          -  End stage renal disease<br>      ;<br>        Inclusion Criteria:<br><br>          -  Adult (according to local legislation) male or female patient<br><br>          -  Chronic hepatitis C (CHC)<br><br>          -  Patients naïve to CHC treatment or patients who received prior interferon-based<br>             therapy for CHC for whom data on treatment received and treatment outcome is<br>             available; information on fibrosis stage prior to previous treatment is also required<br><br>        Exclusion Criteria:<br><br>          -  Co-infection with hepatitis B<br><br>          -  History or evidence of decompensated liver disease<br><br>          -  History of major organ transplantation with an existing functional graft (including<br>             liver transplantation)<br><br>          -  End stage renal disease<br>      ;<br>        Inclusion Criteria:<br><br>          -  Adult (according to local legislation) male or female patient<br><br>          -  Chronic hepatitis C (CHC)<br><br>          -  Patients naïve to CHC treatment or patients who received prior interferon-based<br>             therapy for CHC for whom data on treatment received and treatment outcome is<br>             available; information on fibrosis stage prior to previous treatment is also required<br><br>        Exclusion Criteria:<br><br>          -  Co-infection with hepatitis B<br><br>          -  History or evidence of decompensated liver disease<br><br>          -  History of major organ transplantation with an existing functional graft (including<br>             liver transplantation)<br><br>          -  End stage renal disease<br>